ImmunityBio Inc
(NASDAQ: IBRX)

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

6.150 -

+0.200 (+3.36%)
Range 5.540 - 6.285   (13.45%)
Open 6.010
Previous Close 5.950
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 35,336,363
Value 149,404,915
Remark -
Delayed prices. Updated at 29 Jan 2026 09:15.
Data powered by
View All Events


Top Contributors

robinhan avatar
5701
Followers 2877
Posts 2887

Loading Chart...

Please login to view stock data and analysis